Literature identifier | Study type | Test dosage | Effective dosage | Endocrine-mediated endpoints | Systems-level perturbations |
---|---|---|---|---|---|
PMID:15687051 | IVR | 0.06 mg/kg | 0.06 mg/kg | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 0.06 mg/kg | 0.06 mg/kg | Affects social behavior | Neurological endocrine-mediated perturbations | |
IVR | 0.06 mg/kg | 0.06 mg/kg | Increased spleen weights | Immunological endocrine-mediated perturbations | |
IVR | 0.3 mg/kg | 0.3 mg/kg | Decreased weights of epididymis | Reproductive endocrine-mediated perturbations | |
IVR | 0.3 mg/kg | 0.3 mg/kg | Reduced sperm counts | Reproductive endocrine-mediated perturbations | |
IVR | 0.3 mg/kg | 0.3 mg/kg | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.3 mg/kg | 0.3 mg/kg | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
PMID:16451854 | IVR | 10 mg/kg | 10 mg/kg | Decreased weights of thyroid gland | Metabolic endocrine-mediated perturbations |
IVR | 10 mg/kg | 10 mg/kg | Decreased weights of pituitary gland in offspring | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations | |
IVR | 1 mg/kg | 1 mg/kg | Decreased weights of thyroid gland | Metabolic endocrine-mediated perturbations | |
IVR | 10 mg/kg | 10 mg/kg | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 10 mg/kg | 10 mg/kg | Delayed puberty in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
PMID:17964054 | IVR | 0.06 mg/kg | 0.06 mg/kg | Decrease in T4 levels | Metabolic endocrine-mediated perturbations |
IVR | 0.3 mg/kg | 0.3 mg/kg | Affects xenobiotic metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 0.3 mg/kg | 0.3 mg/kg | Decrease in T4 levels | Metabolic endocrine-mediated perturbations | |
PMID:20488217 | IVR | 0.6 mg/kg | 0.6 mg/kg | Affects the biochemical composition of liver | Hepatic endocrine-mediated perturbations |
IVR | 0.6 mg/kg | 0.6 mg/kg | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 0.6 mg/kg | 0.6 mg/kg | Affects intracellular signaling pathway | Metabolic endocrine-mediated perturbations | |
IVR | 0.6 mg/kg | 0.6 mg/kg | Decreased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 0.6 mg/kg | 0.6 mg/kg | Increased Lactate dehydrogenase (LDH) levels | Metabolic endocrine-mediated perturbations | |
IVR | 1.2 mg/kg | 1.2 mg/kg | Affects the biochemical composition of liver | Hepatic endocrine-mediated perturbations | |
IVR | 1.2 mg/kg | 1.2 mg/kg | Affects intracellular signaling pathway | Metabolic endocrine-mediated perturbations | |
IVR | 1.2 mg/kg | 1.2 mg/kg | Decreased progesterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 1.2 mg/kg | 1.2 mg/kg | Increased Lactate dehydrogenase (LDH) levels | Metabolic endocrine-mediated perturbations | |
IVR | 1.2 mg/kg | 1.2 mg/kg | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
PMID:21783486 | IVR | 452 mg/kg | 452 mg/kg | Affects xenobiotic metabolism | Metabolic endocrine-mediated perturbations |
IVR | 452 mg/kg | 452 mg/kg | Decrease in T4 levels | Metabolic endocrine-mediated perturbations |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.